King & Wood Mallesons has advised Spanish Private Equity firm Ysios Capital on the launch of its third fund, Ysios BioFund III
Ysios BioFund III has a committed amount of €155 million and a final target size of €200 million. The new investment vehicle will invest in biotechnological companies, mainly in Europe. The initial investment will range between €5 and €10 million up to a maximum of €20 million cumulative, but the fund may also invest in up to three seed rounds committing lower amounts.
With this new fund, Ysios, a leading Spanish independent Venture Capital firm, expands its investor base, attracting new national institutional investors, international family offices, and the European Investment Fund through the European Fund for Strategic Investments (EFSI) with the support of the European Union under the Investment Plan for Europe.
KWM has previously advised Ysios on the structuring of its funds Ysios BioFund I and Ysios BioFund II.
King & Wood Mallesons advised Ysios with a team led by Madrid office Funds head partner Isabel Rodríguez (pictured), along with Funds partner Ildefonso Alier (pictured) and associate María Mata.